Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling

scientific article published in September 1993

Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.RES.73.3.596
P698PubMed publication ID7688670
P5875ResearchGate publication ID15509835

P2093author name stringSchreiber SL
Victor RG
Alberg DG
Belshaw PJ
Ermel LD
Lyson T
P433issue3
P304page(s)596-602
P577publication date1993-09-01
P1433published inCirculation ResearchQ2599020
P1476titleCyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling
P478volume73

Reverse relations

cites work (P2860)
Q47326906An Elastomeric Polymer Matrix, PEUU-Tac, Delivers Bioactive Tacrolimus Transdurally to the CNS in Rat.
Q77749256C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potential
Q48738651Calcineurin inhibitor, FK506, prevents reduction in the binding capacity of cyclic AMP-dependent protein kinase in ischemic gerbil brain
Q74300246Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension
Q41468953Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription
Q34976738Cardiovascular toxicities of immunosuppressive agents
Q34241121Chronic rejection
Q43959172Contractile effects of tacrolimus in human and rat isolated renal arteries
Q34306937Controlling Signal Transduction with Synthetic Ligands
Q26269978Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
Q35873547Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity
Q73740432FK506-binding proteins regulate smooth muscle contractility by altering neurotransmitter release
Q92454801Hurdles to Cardioprotection in the Critically Ill
Q41941546Immunophilin regulation of neurotransmitter release
Q38460316Inflammatory mimetic microfluidic chip by immobilization of cell adhesion molecules for T cell adhesion
Q40568804Macrolides in roles beyond antibiotic therapy
Q33590418NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity
Q34768737Parathyroidectomy after kidney transplantation: short-and long-term impact on renal function
Q40920731Pharmacology of immunosuppressive medications used in renal diseases and transplantation
Q28370952Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity
Q34111952Presynaptic modulation of cortical synaptic activity by calcineurin.
Q34547749Reducing adverse effects of immunosuppressive agents in kidney transplant recipients
Q42129809Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats
Q36849244Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension.
Q35125746Sirolimus: its discovery, biological properties, and mechanism of action
Q38112066The sympathetic nervous system in chronic kidney disease.
Q54174772Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.
Q33436612Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors

Search more.